A BTK inhibitor combined with standard R-CHOP produced rapid, PET-defined complete remission in high-risk DLBCL-type Richter syndrome with TP53 deletion. Delaying ibrutinib until cycle 2 was used as a ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
ABSTRACT: Objective: To explore the risk factors for perianal infections in patients with neutropenia and evaluate the effectiveness of different preventive measures. Methods: A retrospective analysis ...
The researchers determined the maximum tolerated nivolumab dose to be 240 mg and the overall response rate was 100% among patients with efficacy data available. Consequently, clinicians have aimed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results